Chronic muscle stimulation improves insulin sensitivity while increasing subcellular lipid droplets and reducing selected diacylglycerol and ceramide species in obese Zucker rats

Diabetologia

Volumn 57, Issue 4, 2014, Pages 832-840

  Holloway, Graham P ^a   Han, Xiao Xia ^a   Jain, Swati S ^a   Bonen, Arend ^a   Chabowski, Adrian ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

DAG; IMTG; Insulin resistance; Intramuscular ceramides; Intramuscular diacylglycerol; Intramuscular triacylglycerol; Lipids; Muscle contraction; TAG

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; FAT DROPLET; FATTY ACID; LIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FAST MUSCLE; FEMALE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; MUSCLE CONTRACTION; MUSCLE EXCITATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; CERAMIDES; DIGLYCERIDES; FEMALE; INSULIN; INSULIN RESISTANCE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OBESITY; RATS; RATS, ZUCKER; TRIGLYCERIDES;

EID: 84896072778     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3169-0     Document Type: Article

References (40)

1. Muoio DM (2010) Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim Biophys Acta 1801:281-8
2. Chavez JA, Summers SA (2010) Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim Biophys Acta 1801:252-65
3. Lee JS, Pinnamaneni SK, Eo SJ et al (2006) Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 100:1467-74
4. Pan DA, Lillioja S, Kriketos AD et al (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-8 (Pubitemid 27220998)
5. Goodpaster BH, He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86:5755-61 (Pubitemid 33152620)
6. Amati F, Dube JJ, Alvarez-Carnero E et al (2011) Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60:2588-97
7. Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH (2007) Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117:1679-89 (Pubitemid 46871352)
8. Liu L, Shi X, Choi CS et al (2009) Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1. Diabetes 58:2516-24
9. Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-11 (Pubitemid 34729001)
10. Wright LE, Brandon AE, Hoy AJ et al (2011) Amelioration of lipid-induced insulin resistance in rat skeletal muscle by overexpression of Pgc-1β involves reductions in long-chain acyl-CoA levels and oxidative stress. Diabetologia 54:1417-26
11. Chibalin AV, Leng Y, Vieira E et al (2008) Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132:375-86 (Pubitemid 351191998)
12. Coen PM, Hames KC, Leachman EM et al (2013) Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity. Obesity (Silver Spring). doi:10.1002/oby.20381
13. Coen PM, Dube JJ, Amati F et al (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59:80-8
14. Turner N, Kowalski GM, Leslie SJ et al (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56:1638-48
15. Bergman BC, Hunerdosse DM, Kerege A, Playdon MC, Perreault L (2012) Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans. Diabetologia 55:1140-50
16. Jocken JW, Goossens GH, Boon H et al (2013) Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance. Diabetologia 56:2255-65
17. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42-72
18. Schmitz-Peiffer C, Craig DL, Biden TJ (1999) Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-10
19. Adams JM 2nd, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31 (Pubitemid 38044694)
20. Bruce CR, Risis S, Babb JR et al (2012) Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 61:3148-55
21. Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167-79
22. Bosma M, Hesselink MK, Sparks LM et al (2012) Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels. Diabetes 61:2679-90
23. Skovbro M, Baranowski M, Skov-Jensen C et al (2008) Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 51:1253-60
24. Nielsen J, Mogensen M, Vind BF et al (2010) Increased subsarcolemmal lipids in type 2 diabetes. Effect of training on localization of lipids, mitochondria and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol Metab 298:E706-13
25. Lally JS, Snook LA, Han XX, Chabowski A, Bonen A, Holloway GP (2012) Subcellular lipid droplet distribution in red and white muscles in the obese Zucker rat. Diabetologia 55:479-88
26. Benton CR, Nickerson JG, Lally J et al (2008) Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in SS, not IMF, mitochondria. J Biol Chem 283:4228-40
27. Benton CR, Holloway GP, Han XX et al (2010) Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia 53:2008-19
28. Alkhateeb H, Chabowski A, Glatz JFC, Luiken JFP, Bonen A (2007) Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am J Physiol Endocrinol Metab 293:E783-93 (Pubitemid 47358991)
29. Holloway GP, Gurd BJ, Snook LA, Lally J, Bonen A (2010) Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats. Diabetes 59:819-28
30. Holloway GP, Snook LA, Harris RJ, Glatz JFC, Luiken LJFP, Bonen A (2010) In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and LCFA oxidation. J Physiol Lond 589:169-80
31. Dube JJ, Amati F, Stefanovic-Racic M, Toledo FG, Sauers SE, Goodpaster BH (2008) Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am J Physiol Endocrinol Metab 294:E882-8
32. Bruce CR, Thrush AB, Mertz VA et al (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291:E99-107
33. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA (2004) Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47:23-30 (Pubitemid 38141936)
34. Kim HJ, Lee JS, Kim CK (2004) Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. Eur J Appl Physiol 93:353-8 (Pubitemid 39534639)
35. Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101-9 (Pubitemid 37329976)
36. van Hees AM, Jans A, Hul GB, Roche HM, Saris WH, Blaak EE (2011) Skeletal muscle fatty acid handling in insulin resistant men. Obesity (Silver Spring) 19:1350-9
37. Eichmann TO, Kumari M, Haas JT et al (2012) Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases. J Biol Chem 287:41446-57
38. Bonen A, Parolin ML, Steinberg GR et al (2004) Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. Faseb J 18:1144-6 (Pubitemid 39561551)
39. Aguer C, Mercier J, Man CY et al (2010) Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients. Diabetologia 53:1151-63
40. Holloway GP, Benton C, Mullen KL et al (2009) In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab 296:E738-47